Does RISANKIZUMAB-RZAA Cause Confusional state? 154 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 154 reports of Confusional state have been filed in association with RISANKIZUMAB-RZAA. This represents 0.2% of all adverse event reports for RISANKIZUMAB-RZAA.
154
Reports of Confusional state with RISANKIZUMAB-RZAA
0.2%
of all RISANKIZUMAB-RZAA reports
4
Deaths
90
Hospitalizations
How Dangerous Is Confusional state From RISANKIZUMAB-RZAA?
Of the 154 reports, 4 (2.6%) resulted in death, 90 (58.4%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Confusional state Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 154 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Confusional state?
METHOTREXATE (4,962)
ACETAMINOPHEN (4,630)
OXYCODONE (4,599)
PREDNISONE (4,441)
ADALIMUMAB (4,399)
RITUXIMAB (4,020)
TOCILIZUMAB (3,949)
ABATACEPT (3,879)
LEFLUNOMIDE (3,795)
PIMAVANSERIN (3,779)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Confusional state Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA